Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-02 @ 1:14 PM
Study NCT ID:
NCT02817451
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2016-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-27
First Submit QC Date:
None
Study First Post Date:
2016-06-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-04-05
Last Update Post Date Type:
ACTUAL